Many protocols for inducing the development ESC and iPSC into clinically relevant cell types rely on the formation of embryoid bodies (EBs), which are 3-dimensional aggregates of cells. In addition to being labor-intensive, current methods for making EBs results in aggregates that are inconsistent in size and shape, leading to inefficient differentiation.
For more information about the AggreWell400 plates, visit www.stemcell.com/News_Info/aggrewell400_release.aspx .
STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, is a privately-owned biotechnology company based in Vancouver, Canada. Driven by science, STEMCELL Technologies delivers over 800 products to more than 70 countries worldwide including mTeSR1, a defined, feeder-independent medium for hESC and hiPSC. To learn more about how STEMCELL Technologies helps to make research work, visit www.stemcell.com .
This is cache, read story here